Study 3 of 4 for search of: "Botulism"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Treatment of Survivors After Botulism Outbreak
This study has been completed.
Sponsors and Collaborators: Rajavithi Hospital
Clinical Molecular Biological Center,Department of Education and Research, Rajavithi hospital: Thailand
Information provided by: Rajavithi Hospital
ClinicalTrials.gov Identifier: NCT00314080
  Purpose

Background. Northern Thailand's biggest botulism outbreak to date occurred on 14 March 2006 and affected 209 people. Of these, 42 developed respiratory failure, and 25 of those who developed respiratory failure were referred to 9 high facility hospitals for treatment of severe respiratory failure and autonomic nervous system involvement. Among these patients, we aimed to assess the relationship between the rate of ventilator dependence and the occurrence of treatment by day 4 versus day 6 after exposure to bamboo shoots (the source of the botulism outbreak), as well as the relationship between ventilator dependence and negative inspiratory pressure.

Methods. The investigators reviewed the circumstances and timing of symptoms following exposure. Mobile teams treated patients with botulinum antitoxin on day 4 or day 6 after exposure in Nan Hospital (Nan, Thailand). Eighteen patients (in 7 high facility hospitals) with severe respiratory failure received a low- and high-rate repetitive nerve stimulation test, and negative inspiratory pressure was measured.


Condition Intervention
Respiratory Failure
Botulism
Drug: Botulinum AntiToxin
Procedure: neuro-electrophysiologic study, repetitive nerve stimulation
Procedure: Protocol early weaning ventilator after recovery of repetitive nerve stimulation and stable negative inspiratory pressure

MedlinePlus related topics: Botulism
U.S. FDA Resources
Study Type: Observational
Official Title: An Outbreak of Botulism in Thailand: Clinical Manifestations and Management of Severe Respiratory Failure

Further study details as provided by Rajavithi Hospital:

Estimated Enrollment: 18
Study Start Date: March 2006
Estimated Study Completion Date: April 2006
  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusions:

  • Ate the bamboo shoots in Banluang district, on March,14 2006
  • Clinical of respiratory failure and need ventilator assistant
  • Needed to referred to other hospital
  • The staffs of referred hospital willing to participate in the Thai Botulism study group

Exclusion Criteria:

  • Patients who did not eat bamboo shoots in Banluang district on March14,2006.
  • No clinical of respiratory failure.
  • Not referred to other hospital.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00314080

Locations
Thailand
Rajavithi Hospital
Bangkok, Thailand, 10400
Sponsors and Collaborators
Rajavithi Hospital
Clinical Molecular Biological Center,Department of Education and Research, Rajavithi hospital: Thailand
Investigators
Principal Investigator: Subsai Kongsaengdao, M.D. Rajavithi Hospital
  More Information

Pubmed  This link exits the ClinicalTrials.gov site

Publications of Results:
Other Publications:
Study ID Numbers: RVH_CER_001
Study First Received: March 30, 2006
Last Updated: October 23, 2008
ClinicalTrials.gov Identifier: NCT00314080  
Health Authority: Thailand: Ministry of Public Health

Keywords provided by Rajavithi Hospital:
Botulism
Botulinum anti-toxin
Repetitive nerve stimulation
Respiratory failure

Study placed in the following topic categories:
Bacterial Infections
Antitoxins
Neurotoxicity Syndromes
Botulism
Respiration Disorders
Neurotoxicity syndromes
Botulinum Antitoxin
Poisoning
Disorders of Environmental Origin
Gram-Positive Bacterial Infections
Respiratory Insufficiency
Neuromuscular Diseases
Respiratory Tract Diseases
Clostridium Infections

Additional relevant MeSH terms:
Immunologic Factors
Physiological Effects of Drugs
Food Poisoning
Nervous System Diseases
Neuromuscular Junction Diseases
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009